Back to Search
Start Over
Outcomes and Risk Score for Distal Pancreatectomy with Celiac Axis Resection (DP-CAR) : An International Multicenter Analysis
- Source :
- Annals of Surgical Oncology, 26(3), 772. Springer New York, Annals of Surgical Oncology, Annals of surgical oncology, 26(3), 772-781. Springer New York, ANNALS OF SURGICAL ONCOLOGY, Annals of surgical oncology
- Publication Year :
- 2019
-
Abstract
- Background Distal pancreatectomy with celiac axis resection (DP-CAR) is a treatment option for selected patients with pancreatic cancer involving the celiac axis. A recent multicenter European study reported a 90-day mortality rate of 16%, highlighting the importance of patient selection. The authors constructed a risk score to predict 90-day mortality and assessed oncologic outcomes. Methods This multicenter retrospective cohort study investigated patients undergoing DP-CAR at 20 European centers from 12 countries (model design 2000–2016) and three very-high-volume international centers in the United States and Japan (model validation 2004–2017). The area under receiver operator curve (AUC) and calibration plots were used for validation of the 90-day mortality risk model. Secondary outcomes included resection margin status, adjuvant therapy, and survival. Results For 191 DP-CAR patients, the 90-day mortality rate was 5.5% (95 confidence interval [CI], 2.2–11%) at 5 high-volume (≥ 1 DP-CAR/year) and 18% (95 CI, 9–30%) at 18 low-volume DP-CAR centers (P = 0.015). A risk score with age, sex, body mass index (BMI), American Society of Anesthesiologists (ASA) score, multivisceral resection, open versus minimally invasive surgery, and low- versus high-volume center performed well in both the design and validation cohorts (AUC, 0.79 vs 0.74; P = 0.642). For 174 patients with pancreatic ductal adenocarcinoma, the R0 resection rate was 60%, neoadjuvant and adjuvant therapies were applied for respectively 69% and 67% of the patients, and the median overall survival period was 19 months (95 CI, 15–25 months). Conclusions When performed for selected patients at high-volume centers, DP-CAR is associated with acceptable 90-day mortality and overall survival. The authors propose a 90-day mortality risk score to improve patient selection and outcomes, with DP-CAR volume as the dominant predictor. Electronic supplementary material The online version of this article (10.1245/s10434-018-07101-0) contains supplementary material, which is available to authorized users.
- Subjects :
- Male
medicine.medical_specialty
Pancreatic Neoplasms/pathology
SURGERY
medicine.medical_treatment
Pancreatectomy/mortality
Pancreatectomy
Celiac artery
Celiac Artery
Pancreatic cancer
medicine.artery
Medicine and Health Sciences
Aged
Female
Follow-Up Studies
Humans
Middle Aged
Pancreatic Neoplasms
Retrospective Studies
Survival Rate
Treatment Outcome
Patient Selection
Journal Article
Medicine
Survival rate
ARTERY
Framingham Risk Score
business.industry
Mortality rate
Celiac Artery/surgery
ADENOCARCINOMA
Retrospective cohort study
medicine.disease
Surgery
ddc
MODEL
Multicenter Study
DEFINITION
Oncology
Hepatobiliary Tumors
VOLUME
Adenocarcinoma
Human medicine
business
Subjects
Details
- Language :
- English
- ISSN :
- 10689265 and 15344681
- Database :
- OpenAIRE
- Journal :
- Annals of Surgical Oncology, 26(3), 772. Springer New York, Annals of Surgical Oncology, Annals of surgical oncology, 26(3), 772-781. Springer New York, ANNALS OF SURGICAL ONCOLOGY, Annals of surgical oncology
- Accession number :
- edsair.doi.dedup.....920e8ebad95d0aa395de5228870ec50e